Point-of-care testing in haemostasis

British Journal of Haematology

Volumn 150, Issue 5, 2010, Pages 501-514

  Perry, David J ^a   Fitzmaurice, David A ^b   Kitchen, Steve ^c   MacKie, Ian J ^d   Mallett, Sue ^e  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Rutledge Mews   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

haemostasis; near patient testing; point of care testing; quality assurance

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; D DIMER; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULATION; BLOOD CLOT LYSIS; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; DIAGNOSTIC ACCURACY; FIBRINOLYSIS; HEART SURGERY; HEMODILUTION; HEMOLYSIS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; INTERNATIONAL NORMALIZED RATIO; PATIENT MONITORING; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTHROMBIN TIME; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY; THROMBIN TIME; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; BLOOD CLOTTING TEST; HEALTH CARE QUALITY; HOSPITAL INFORMATION SYSTEM; PROCEDURES; STANDARDS;

BLOOD COAGULATION TESTS; HEMOSTASIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; QUALITY ASSURANCE, HEALTH CARE; THROMBELASTOGRAPHY; WHOLE BLOOD COAGULATION TIME;

EID: 77955811114     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08223.x     Document Type: Review

References (112)

1. Agarwal, S., Coakley, M., Reddy, K., Riddell, A. Mallett, S. (2006) Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry. Anesthesiology, 105, 676 683.
2. Ak, K., Isbir, C.S., Tetik, S., Atalan, N., Tekeli, A., Aljodi, M., Civelek, A. Arsan, S. (2009) Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. Journal of Cardiac Surgery, 24, 404 410.
3. Avidan, M.S., Da Fonseca, J., Parmar, K., Alcock, E., Ponte, J. Hunt, B.J. (2001) The effects of aprotinin on thromboelastography with three different activators. Anesthesiology, 95, 1169 1174.
4. Baker, P.M., Howgate, S.J., Atherton, J. Keeling, D.M. (2010) Comparison of a point of care device against current laboratory methodology using citrated and EDTA samples for the determination of D-dimers in the exclusion of proximal deep vein thrombosis. International Journal of Laboratory Hematology, doi :.
5. Becker, R.C., Ball, S.P., Eisenberg, P., Borzak, S., Held, A.C., Spencer, F., Voyce, S.J., Jesse, R., Hendel, R., Ma, Y., Hurley, T. Hebert, J. (1999) A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators. American Heart Journal, 137, 59 71.
6. Bowbrick, V.A., Mikhailidis, D.P. Stansby, G. (2000) The use of citrated whole blood in thromboelastography. Anesthesia & Analgesia, 90, 1086 1088.
7. Bowbrick, V.A., Mikhailidis, D.P. Stansby, G. (2003) Influence of platelet count and activity on thromboelastography parameters. Platelets, 14, 219 224.
8. Bracey, A.W., Grigore, A.M. Nussmeier, N.A. (2006) Impact of platelet testing on presurgical screening and implications for cardiac and noncardiac surgical procedures. American Journal of Cardiology, 98, 25N 32N.
9. Briggs, C., Guthrie, D., Hyde, K., Mackie, I., Parker, N., Popek, M., Porter, N. Stephens, C. (2008) Guidelines for point-of-care testing: haematology. British Journal of Haematology, 142, 904 915.
10. Cammerer, U., Dietrich, W., Rampf, T., Braun, S.L. Richter, J.A. (2003) The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesthesia & Analgesia, 96, 51 57, table of contents.
11. Carroll, R.C., Chavez, J.J., Snider, C.C., Meyer, D.S. Muenchen, R.A. (2006) Correlation of perioperative platelet function and coagulation tests with bleeding after cardiopulmonary bypass surgery. Journal of Laboratory & Clinical Medicine, 147, 197 204.
12. Carroll, R.C., Craft, R.M., Langdon, R.J., Clanton, C.R., Snider, C.C., Wellons, D.D., Dakin, P.A., Lawson, C.M., Enderson, B.L. Kurek, S.J. (2009) Early evaluation of acute traumatic coagulopathy by thrombelastography. Translational Research, 154, 34 39.
13. Chavez, J.J., Weatherall, J.S., Strevels, S.M., Liu, F., Snider, C.C. Carroll, R.C. (2004) Evaluation of a point-of-care coagulation analyzer on patients undergoing cardiopulmonary bypass surgery. Journal of Clinical Anesthesia, 16, 7 10.
14. Chen, L., Bracey, A.W., Radovancevic, R., Cooper, Jr., J.R., Collard, C.D., Vaughn, W.K. Nussmeier, N.A. (2004a) Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery, 128, 425 431.
15. Chen, W.H., Lee, P.Y., Ng, W., Tse, H.F. Lau, C.P. (2004b) Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. Journal of the American College of Cardiology, 43, 1122 1126.
16. Choi, T.S., Greilich, P.E., Shi, C., Wilson, J.S., Keller, A. Kroll, M.H. (2002) Point-of-care testing for prothrombin time, but not activated partial thromboplastin time, correlates with laboratory methods in patients receiving aprotinin or epsilon-aminocaproic acid while undergoing cardiac surgery. American Journal of Clinical Pathology, 117, 74 78.
17. Clayton, D.G., Miro, A.M., Kramer, D.J., Rodman, N. Wearden, S. (1995) Quantification of thrombelastographic changes after blood component transfusion in patients with liver disease in the intensive care unit. Anesthesia & Analgesia, 81, 272 278.
18. Coakley, M., Reddy, K., Mackie, I. Mallett, S. (2006) Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. Journal of Cardiothoracic and Vascular Anesthesia, 20, 548 553.
19. Coiffic, A., Cazes, E., Janvier, G., Forestier, F., Lanza, F., Nurden, A. Nurden, P. (1999) Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus. Thrombosis Research, 95, 83 91.
20. Craft, R.M., Chavez, J.J., Bresee, S.J., Wortham, D.C., Cohen, E. Carroll, R.C. (2004) A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. Journal of Laboratory & Clinical Medicine, 143, 301 309.
21. Culliford, A.T., Gitel, S.N., Starr, N., Thomas, S.T., Baumann, F.G., Wessler, S. Spencer, F.C. (1981) Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Annals of Surgery, 193, 105 111.
22. Dempfle, C.E., Korte, W., Schwab, M., Zerback, R. Huisman, M.V. (2006) Sensitivity and specificity of a quantitative point of care D-dimer assay using heparinized whole blood, in patients with clinically suspected deep vein thrombosis. Thrombosis and Haemostasis, 96, 79 83.
23. Despotis, G.J., Summerfield, A.L., Joist, J.H., Goodnough, L.T., Santoro, S.A., Spitznagel, E., Cox, J.L. Lappas, D.G. (1994) Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. Journal of Thoracic and Cardiovascular Surgery, 108, 1076 1082.
24. Despotis, G.J., Levine, V., Filos, K.S., Santoro, S.A., Joist, J.H., Spitznagel, E. Goodnough, L.T. (1996) Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology, 85, 1311 1323.
25. Despotis, G.J., Joist, J.H., Goodnough, L.T., Santoro, S.A. Spitznagel, E. (1997) Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements. Journal of Thoracic and Cardiovascular Surgery, 113, 611 613.
26. Eiswirth, G., Walch, S. Bommer, J. (1998) New bedside test for monitoring anticoagulation during hemodialysis. Artificial Organs, 22, 346 348.
27. Favaloro, E.J. (2009) Internal quality control and external quality assurance of platelet function tests. Seminars in Thrombosis and Hemostasis, 35, 139 149.
28. Fergusson, D.A., Hebert, P.C., Mazer, C.D., Fremes, S., MacAdams, C., Murkin, J.M., Teoh, K., Duke, P.C., Arellano, R., Blajchman, M.A., Bussieres, J.S., Cote, D., Karski, J., Martineau, R., Robblee, J.A., Rodger, M., Wells, G., Clinch, J. Pretorius, R. (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. New England Journal of Medicine, 358, 2319 2331.
29. Ferring, M., Reber, G., de Moerloose, P., Merlani, P., Diby, M. Ricou, B. (2001) Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients. Canadian Journal of Anaesthesia, 48, 1155 1160.
30. Forestier, F., Coiffic, A., Mouton, C., Ekouevi, D., Chene, G. Janvier, G. (2002) Platelet function point-of-care tests in post-bypass cardiac surgery: are they relevant? British Journal of Anaesthesia, 89, 715 721.
31. Frank, R.D., Brandenburg, V.M., Lanzmich, R. Floege, J. (2004) Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis. Nephrology Dialysis Transplantation, 19, 1552 1558.
32. Gardiner, C., Pennaneac'h, C., Walford, C., Machin, S.J. Mackie, I.J. (2005) An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. British Journal of Haematology, 128, 842 848.
33. Gardiner, C., Longair, I., Pescott, M.A., Erwin, H., Hills, J., Machin, S.J. Cohen, H. (2009) Self-monitoring of oral anticoagulation: does it work outside trial conditions? Journal of Clinical Pathology, 62, 168 171.
34. Geersing, G.J., Janssen, K.J., Oudega, R., Bax, L., Hoes, A.W., Reitsma, J.B. Moons, K.G. (2009) Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis. BMJ, 339, b2990.
35. Gosselin, R., Owings, J.T., White, R.H., Hutchinson, R., Branch, J., Mahackian, K., Johnston, M. Larkin, E.C. (2000) A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thrombosis and Haemostasis, 83, 698 703.
36. Gravlee, G.P., Arora, S., Lavender, S.W., Mills, S.A., Hudspeth, A.S., Cordell, A.R., James, R.L., Brockschmidt, J.K. Stuart, J.J. (1994) Predictive value of blood clotting tests in cardiac surgical patients. Annals of Thoracic Surgery, 58, 216 221.
37. Greiber, S., Weber, U., Galle, J., Bramer, P. Schollmeyer, P. (1997) Activated clotting time is not a sensitive parameter to monitor anticoagulation with low molecular weight heparin in hemodialysis. Nephron, 76, 15 19.
38. Harding, S.A., Mallett, S.V., Peachey, T.D. Cox, D.J. (1997) Use of heparinase modified thrombelastography in liver transplantation. British Journal of Anaesthesia, 78, 175 179.
39. Harrison, P. (2005) The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. British Journal of Haematology, 130, 3 10.
40. Harrison, P. Mumford, A. (2009) Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Seminars in Thrombosis and Hemostasis, 35, 150 157.
41. Harrison, P., Frelinger, III., A.L., Furman, M.I. Michelson, A.D. (2007) Measuring antiplatelet drug effects in the laboratory. Thrombosis Research, 120, 323 336.
42. Hattersley, P.G. (1966) Activated coagulation time of whole blood. JAMA, 196, 436 440.
43. Hayward, C.P. Eikelboom, J. (2007) Platelet function testing: quality assurance. Seminars in Thrombosis and Hemostasis, 33, 273 282.
44. Heim, S.W., Schectman, J.M., Siadaty, M.S. Philbrick, J.T. (2004) D-dimer testing for deep venous thrombosis: a metaanalysis. Clinical Chemistry, 50, 1136 1147.
45. Henry, T.D., Satran, D., Knox, L.L., Iacarella, C.L., Laxson, D.D. Antman, E.M. (2001) Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? American Heart Journal, 142, 590 593.
46. von Heymann, C., Schoenfeld, H., Sander, M., Ziemer, S., Grubitzsch, H. Spies, C. (2005) Clopidogrel-related refractory bleeding after coronary artery bypass graft surgery: a rationale for the use of coagulation factor concentrates? The Heart Surgery Forum, 8, E39 E41.
47. Hobson, A.R., Agarwala, R.A., Swallow, R.A., Dawkins, K.D. Curzen, N.P. (2006) Thrombelastography: current clinical applications and its potential role in interventional cardiology. Platelets, 17, 509 518.
48. Hunt, B.J., Segal, H.C. Yacoub, M. (1992) Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 104, 211 212.
49. Hvitfeldt Poulsen, L., Christiansen, K., Sorensen, B. Ingerslev, J. (2006) Whole blood thrombelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients. Scandinavian Journal of Clinical and Laboratory Investigation, 66, 329 336.
50. Jaryno, S., Bennett, K., Loder, C., Zucker, M.L., Pan, C.M. LaDuca, F.M. (2002) Validation of a new whole blood coagulation monitoring system. The Journal of Extra-corporeal Technology, 34, 271 275.
51. Jones, K., Nasrallah, F., Darling, E., Clay, N. Searles, B. (2004) The in vitro effects of aprotinin on twelve different ACT tests. The Journal of Extra-corporeal Technology, 36, 51 57.
52. de Jong, M.A. (1999) High dose thrombin time versus the activated clotting time during cardiopulmonary bypass. The Journal of Extra-corporeal Technology, 31, 76 79.
53. Kang, Y. (1993) Clinical use of synthetic antifibrinolytic agents during liver transplantation. Seminars in Thrombosis and Hemostasis, 19, 258 261.
54. Kang, Y. (1995) Thromboelastography in liver transplantation. Seminars in Thrombosis and Hemostasis, 21 (Suppl. 4 34 44.
55. Kang, Y. (1997) Transfusion based on clinical coagulation monitoring does reduce hemorrhage during liver transplantation. Liver Transplantation and Surgery, 3, 655 659.
56. Karabulut, H., Toraman, F., Evrenkaya, S., Goksel, O., Tarcan, S. Alhan, C. (2004) Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery. European Journal of Cardio-thoracic Surgery, 25, 419 423.
57. Kaufmann, C.R., Dwyer, K.M., Crews, J.D., Dols, S.J. Trask, A.L. (1997) Usefulness of thrombelastography in assessment of trauma patient coagulation. Journal of Trauma, 42, 716 720 discussion 720-712.
58. Keeling, D.M., Mackie, I.J., Moody, A. Watson, H.G. (2004) The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D-dimer assays to reduce the need for diagnostic imaging. British Journal of Haematology, 124, 15 25.
59. Kettner, S.C., Panzer, O.P., Kozek, S.A., Seibt, F.A., Stoiser, B., Kofler, J., Locker, G.J. Zimpfer, M. (1999) Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesthesia & Analgesia, 89, 580 584.
60. Kitchen, S., Walker, I.D., Woods, T.A. Preston, F.E. (1994) Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation. Thrombosis and Haemostasis, 72, 426 429.
61. Kitchen, D.P., Munroe, S., Kitchen, S., Jennings, I., Woods, T.A. Walker, I. (2009) Establishment of an external quality assessment programme for users of activated clotting time. Journal of Thrombosis and Haemostasis, 7, PP-MO-116.
62. Lasne, D., Fiemeyer, A., Chatellier, G., Chammas, C., Baron, J.F. Aiach, M. (2000) A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft. Thrombosis and Haemostasis, 84, 794 799.
63. Lawrence, M., Mixon, T.A., Cross, D., Gantt, D.S. Dehmer, G.J. (2004) Assessment of anticoagulation using activated clotting times in patients receiving intravenous enoxaparin during percutaneous coronary intervention. Catheterization and Cardiovascular Interventions, 61, 52 55.
64. Leong, J.Y., Baker, R.A., Shah, P.J., Cherian, V.K. Knight, J.L. (2005) Clopidogrel and bleeding after coronary artery bypass graft surgery. Annals of Thoracic Surgery, 80, 928 933.
65. Levrat, A., Gros, A., Rugeri, L., Inaba, K., Floccard, B., Negrier, C. David, J.S. (2008) Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. British Journal of Anaesthesia, 100, 792 797.
66. Leyvi, G., Shore-Lesserson, L., Harrington, D., Vela-Cantos, F. Hossain, S. (2001) An investigation of a new activated clotting time "MAX-ACT" in patients undergoing extracorporeal circulation. Anesthesia & Analgesia, 92, 578 583.
67. Linkins, L.A., Julian, J.A., Rischke, J., Hirsh, J. Weitz, J.I. (2002) In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation. Thrombosis Research, 107, 241 244.
68. Marmur, J.D., Anand, S.X., Bagga, R.S., Fareed, J., Pan, C.M., Sharma, S.K. Richard, M.F. (2003) The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration. Journal of the American College of Cardiology, 41, 394 402.
69. McCrath, D.J., Cerboni, E., Frumento, R.J., Hirsh, A.L. Bennett-Guerrero, E. (2005) Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesthesia & Analgesia, 100, 1576 1583.
70. Merlani, P.G., Chenaud, C., Cottini, S., Reber, G., Garnerin, P., de Moerloose, P. Ricou, B. (2006) Point of care management of heparin administration after heart surgery: a randomized, controlled trial. Intensive Care Medicine, 32, 1357 1364.
71. MHRA (2010) Device Bulletin Management and Use of IVD Point of Care Test Devices. In: http://www.mhra.gov.uk/Publications/Safetyguidance/DeviceBulletins/ CON071082.
72. Michelson, A.D., Frelinger, III., A.L. Furman, M.I. (2006) Current options in platelet function testing. American Journal of Cardiology, 98, 4N 10N.
73. Mongan, P.D. Hosking, M.P. (1992) The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology, 77, 38 46.
74. Murray, D.J., Brosnahan, W.J., Pennell, B., Kapalanski, D., Weiler, J.M. Olson, J. (1997) Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. Journal of Cardiothoracic and Vascular Anesthesia, 11, 24 28.
75. Nielsen, V.G., Cohen, B.M. Cohen, E. (2006) Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. Blood Coagulation and Fibrinolysis, 17, 75 81.
76. Nuttall, G.A., Oliver, Jr., W.C., Beynen, F.M., Dull, J.J., Murray, M.J. Nichols, W.L. (1993) Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia, 7, 402 409.
77. Nuttall, G.A., Oliver, W.C., Beynen, F.M., Santrach, P.J., Strickland, R.A. Murray, M.J. (1995) Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia, 9, 355 361.
78. O'Donnell, J., Riddell, A., Owens, D., Handa, A., Pasi, J., Hamilton, G. Perry, D.J. (2004) Role of the Thrombelastograph as an adjunctive test in thrombophilia screening. Blood Coagulation and Fibrinolysis, 15, 207 211.
79. Paniccia, R., Fedi, S., Carbonetto, F., Noferi, D., Conti, P., Bandinelli, B., Giusti, B., Evangelisti, L., Pretelli, P., Palmarini, M.F., Abbate, R. Prisco, D. (2003) Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. Anesthesiology, 99, 54 59.
80. Payne, D.A., Hayes, P.D., Jones, C.I., Belham, P., Naylor, A.R. Goodall, A.H. (2002) Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. Journal of Vascular Surgery, 35, 1204 1209.
81. Plotkin, A.J., Wade, C.E., Jenkins, D.H., Smith, K.A., Noe, J.C., Park, M.S., Perkins, J.G. Holcomb, J.B. (2008) A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. Journal of Trauma, 64, S64 S68.
82. Prisco, D. Paniccia, R. (2003) Point-of-care testing of hemostasis in cardiac surgery. Thrombosis Journal, 1, 1.
83. Raman, S. Silverman, N.A. (2001) Clinical utility of the platelet function analyzer (PFA-100) in cardiothoracic procedures involving extracorporeal circulation. Journal of Thoracic and Cardiovascular Surgery, 122, 190 191.
84. Reiner, J.S., Coyne, K.S., Lundergan, C.F. Ross, A.M. (1994) Bedside monitoring of heparin therapy: comparison of activated clotting time to activated partial thromboplastin time. Catheterization and Cardiovascular Diagnosis, 32, 49 52.
85. Reiss, R.A., Haas, C.E., Griffis, D.L., Porter, B. Tara, M.A. (2002) Point-of-care versus laboratory monitoring of patients receiving different anticoagulant therapies. Pharmacotherapy, 22, 677 685.
86. Ronald, A. Dunning, J. (2005) Can the use of thromboelastography predict and decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? Interactive Cardiovascular and Thoracic Surgery, 4, 456 463.
87. Royston, D. von Kier, S. (2001) Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. British Journal of Anaesthesia, 86, 575 578.
88. Rugeri, L., Levrat, A., David, J.S., Delecroix, E., Floccard, B., Gros, A., Allaouchiche, B. Negrier, C. (2007) Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. Journal of Thrombosis and Haemostasis, 5, 289 295.
89. Samama, C.M. Ozier, Y. (2003) Near-patient testing of haemostasis in the operating theatre: an approach to appropriate use of blood in surgery. Vox Sanguinis, 84, 251 255.
90. Schroeder, A.P., Knudsen, L.L., Husted, S.E., Knudsen, L. Ingerslev, J. (2001) Bedside coagulometry during intravenous heparin therapy after coronary angioplasty. Journal of Thrombosis and Thrombolysis, 12, 157 163.
91. Shore-Lesserson, L. (2005) Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function. Seminars in Cardiothoracic and Vascular Anesthesia, 9, 41 52.
92. Shore-Lesserson, L., Manspeizer, H.E., DePerio, M., Francis, S., Vela-Cantos, F. Ergin, M.A. (1999a) Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesthesia & Analgesia, 88, 312 319.
93. Shore-Lesserson, L., Ammar, T., DePerio, M., Vela-Cantos, F., Fisher, C. Sarier, K. (1999b) Platelet-activated clotting time does not measure platelet reactivity during cardiac surgery. Anesthesiology, 91, 362 368.
94. Sie, P. Steib, A. (2006) Central laboratory and point of care assessment of perioperative hemostasis. Canadian Journal of Anaesthesia, 53, S12 S20.
95. Slaughter, T.F., Sreeram, G., Sharma, A.D., El-Moalem, H., East, C.J. Greenberg, C.S. (2001) Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagulation and Fibrinolysis, 12, 85 93.
96. Smythe, M.A., Koerber, J.M., Westley, S.J., Nowak, S.N., Begle, R.L., Balasubramaniam, M. Mattson, J.C. (2001) Use of the activated partial thromboplastin time for heparin monitoring. American Journal of Clinical Pathology, 115, 148 155.
97. Solvik, U.O., Stavelin, A., Christensen, N.G. Sandberg, S. (2006) External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation, 66, 337 349.
98. Sorensen, E.R., Lorme, T.B. Heath, D. (2005) Thromboelastography: a means to transfusion reduction. Nursing Management, 36, 27 33 quiz 33-34.
99. Spiess, B.D. (1996) Coagulation monitoring in the perioperative period. Acta Anaesthesiologica Scandinavica. Supplementum, 109, 77 79.
100. Spiess, B.D., Tuman, K.J., McCarthy, R.J., DeLaria, G.A., Schillo, R. Ivankovich, A.D. (1987) Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. Journal of Clinical Monitoring, 3, 25 30.
101. Spiess, B.D., Gillies, B.S., Chandler, W. Verrier, E. (1995) Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. Journal of Cardiothoracic and Vascular Anesthesia, 9, 168 173.
102. Swallow, R.A., Agarwala, R.A., Dawkins, K.D. Curzen, N.P. (2006) Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy? Platelets, 17, 385 392.
103. Taylor, C.T., Petros, W.P. Ortel, T.L. (1999) Two instruments to determine activated partial thromboplastin time: implications for heparin monitoring. Pharmacotherapy, 19, 383 387.
104. Tripodi, A., Bressi, C., Carpenedo, M., Chantarangkul, V., Clerici, M. Mannucci, P.M. (2004) Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation. Thrombosis Research, 113, 35 40.
105. Tuman, K.J., McCarthy, R.J., Djuric, M., Rizzo, V. Ivankovich, A.D. (1994) Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay. Journal of Cardiothoracic and Vascular Anesthesia, 8, 144 149.
106. Wang, J.S., Lin, C.Y., Hung, W.T. Karp, R.B. (1992) Monitoring of heparin-induced anticoagulation with kaolin-activated clotting time in cardiac surgical patients treated with aprotinin. Anesthesiology, 77, 1080 1084.
107. Wang, J.S., Lin, C.Y. Karp, R.B. (1994) Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients. Anesthesia & Analgesia, 79, 9 13.
108. Welsby, I.J., McDonnell, E., El-Moalem, H., Stafford-Smith, M. Toffaletti, J.G. (2002) Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass. Journal of Clinical Monitoring, 17, 287 292.
109. Westbrook, A.J., Olsen, J., Bailey, M., Bates, J., Scully, M. Salamonsen, R.F. (2009) Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. Heart, Lung & Circulation, 18, 277 288.
110. Wilson, J.M., Gilbert, J., Harlan, M., Bracey, A., Allison, P., Schooley, C. Pinto, K. (2005) High-dose intravenous dalteparin can be monitored effectively using standard coagulation times. Clinical and Applied Thrombosis/Hemostasis, 11, 127 138.
111. Yende, S. Wunderink, R.G. (2001) Effect of clopidogrel on bleeding after coronary artery bypass surgery. Critical Care Medicine, 29, 2271 2275.
112. Zabel, K.M., Granger, C.B., Becker, R.C., Bovill, E.G., Hirsh, J., Aylward, P.E., Topol, E.J. Califf, R.M. (1998) Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. American Heart Journal, 136, 868 876.